IsaiX President, Steve Gregory, joins on stage as Bruce Brydon, Chairman and CEO of Trimel Pharmaceuticals Corporation, opens the Toronto Stock Exchange this morning. Trimel is primarily focused on improving the utility of known pharmaceutical compounds by employing dosing technologies that are specifically designed to avoid first pass metabolism. Trimel Pharmaceuticals Corporation trades on the Toronto Stock Exchange under the stock symbol TRL. For more information visit www.trimelpharmaceuticals.com.
